Quick answer
Stem cell therapy is an advanced method focusing on regenerating deteriorated liver cells by injecting autologous stem cells directly into the hepatic artery to minimize immune reaction. This process promotes new liver tissue formation, enhances overall liver function, and manages complications such as ascites based on EHL team assessments.
Key takeaways
- Utilizes autologous adipose-derived Mesenchymal stem cells for safety.
- Focuses on restoring liver elasticity and improving liver volume.
- Direct hepatic artery injection allows cells to target specific areas effectively.
- Conducted under GMP standards and MFDS South Korea regulations.
Advancements in Stem Cell Therapy for Liver Cirrhosis
Liver cirrhosis involves tissue deterioration leading to fibrosis, which impairs vital bodily functions. EHL BIO utilizes innovative regenerative medicine as a supportive pathway, leveraging the unique ability of stem cells to differentiate into specialized cells for recovery.
The core of this therapy involves using the patient's own adipose-derived stem cells (Autologous), which effectively minimizes the risk of immune rejection. Once these cells are cultured using advanced technology to reach optimal quantity and quality, medical teams deliver them back to the body with the goal of regenerating liver tissue and restoring its functional capacity as assessed by the EHL team.
Mechanisms of Repair and Tissue Regeneration
Stem cell therapy for cirrhosis focuses on the transformation process to generate new liver tissue through the 'Homing Effect,' which directs cells to areas needing recovery.
Case studies indicate that stem cell transplantation contributes to making fibrotic liver tissue more elastic and soft. It also aids in improving overall liver function markers, such as managing ascites and normalizing liver enzymes. This approach focuses on recovery goals and quality of life compared to conventional management.
Our goal is to use stem cell technology to transform liver degeneration into a recovery filled with hope and improved quality of life.
Safety and Cultivation Standards
EHL BIO prioritizes cell safety and quality, utilizing Class 100 GMP-certified facilities recognized by relevant authorities in South Korea.
Through our patented isolation and cultivation technologies, we can increase cell yields up to 1,000 times higher than industry standards while maintaining exceptional cell viability. All processes are governed by applicable regulations, ensuring that every production lot is of high purity, free from contaminants, and ready for effective recovery goals.
Service Procedures and Thai Coordination Team
For Thai patients, EHL Thailand provides dedicated coordination, starting from initial consultation and medical record review by our Korean specialists. Once candidacy is confirmed, a personalized travel and recovery plan is established for the EHL Cell Clinic in Seoul.
The process involves a physical examination and a minimally invasive fat tissue collection. These cells are then cultured in high-standard laboratories before being administered according to the recovery plan. Our team continues to monitor progress to ensure recovery goals and long-term quality of life.
Frequently asked questions
How safe is using autologous adipose-derived stem cells?
It is safe because it uses the patient's own cells (Autologous), reducing immune reaction risks. The process is conducted in GMP-certified laboratories with high-level cleanliness systems.
How long does the cell cultivation process take?
Typically, the process takes about 4 weeks to achieve the optimal quantity and quality of cells required for effective recovery goals.
What are the expected recovery goals for cirrhosis care?
The focus is on reducing fibrosis, increasing liver tissue elasticity, improving liver function, and alleviating complications like ascites. Recovery results depend on individual medical evaluations.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.
